MPP6 Activators are a diverse collection of chemical compounds that indirectly stimulate the functional activity of MPP6, a protein involved in mRNA processing and stabilization. Forskolin and 8-Br-cAMP, through their ability to raise intracellular cAMP levels, indirectly facilitate MPP6's role by activating protein kinase A (PKA). This activation leads to the phosphorylation of proteins within the spliceosome complex where MPP6 operates. Similarly, db-cAMP, another cAMP analog, bolsters PKA activity, potentially influencing MPP6 activity by modifying the phosphorylation patterns of proteins associated with RNA splicing. Ionomycin and Thapsigargin, by increasing intracellular calcium levels, activate calcium-dependent pathways that may indirectly enhance MPP6's interaction with mRNA processing factors, thus supporting its functional activity. Calyculin A and Okadaic Acid, as inhibitors of PP1 and PP2A, maintain a higher phosphorylation state of proteins, which could indirectly elevate MPP6's function by affecting the phosphorylation dynamics of spliceosome-associated proteins. Complementing these activators, Phorbol 12-myristate 13-acetate (PMA) triggers protein kinase C (PKC), which may phosphorylate proteins that interact with MPP6, thereby modulating its role in RNA processing. Bisindolylmaleimide I (Bis I), through its inhibition of PKC, may also impact MPP6 activity by altering the phosphorylation state of proteins within the RNA processing pathway.
Epigallocatechin Gallate (EGCG) serves to dampen the activityof multiple kinases, potentially shifting the signaling balance to favor MPP6-mediated mRNA processing by reducing competitive phosphorylation. Anisomycin, which inhibits protein synthesis, may activate stress-activated protein kinases, indirectly promoting MPP6's function during cellular stress response. Furthermore, Sphingosine-1-phosphate (S1P) operates through its receptors to initiate downstream effects, including the activation of MAPK and PI3K pathways, which could indirectly buttress MPP6's activity by influencing the various signaling cascades that intersect with mRNA processing. Collectively, these MPP6 Activators, by targeting different signaling pathways, work in concert to enhance the functional activity of MPP6 in its pivotal role within the spliceosome complex, ensuring the fidelity and efficiency of mRNA processing and stabilization without directly upregulating its expression or function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calmodulin-dependent pathways, potentially enhancing the interaction of MPP6 with other mRNA processing factors through modulation of protein conformation and function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate substrates that may modulate MPP6 activity in RNA processing. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
A cAMP analog that activates PKA, potentially enhancing MPP6's interaction with other proteins in the spliceosome complex. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
An inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), leading to increased protein phosphorylation levels that could influence MPP6 function in RNA processing by altering the phosphorylation state of associated proteins. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Another PP1 and PP2A inhibitor, it can increase the phosphorylation state of proteins potentially associated with MPP6, affecting its role in mRNA splicing. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A membrane-permeable cAMP analog that activates PKA, potentially influencing MPP6 activity by phosphorylation of spliceosome-related proteins. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Inhibits multiple kinases, potentially reducing competitive phosphorylation and enhancing MPP6-mediated mRNA processing by shifting the signaling balance. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Inhibits protein synthesis and can activate stress-activated protein kinases (SAPKs), which might indirectly enhance MPP6's role in mRNA processing under stress conditions. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P receptor activation can lead to various downstream effects including activation of MAPK and PI3K pathways, potentially enhancing MPP6's activity in mRNA processing through these signaling cascades. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A specific PKC inhibitor that may indirectly enhance MPP6 activity by changing the phosphorylation state of proteins in the RNA processing pathway that interact with MPP6. | ||||||